Lewis Y (Tumor Marker) (A70-C/C8), 1mg/mL Antibody | BNUM1411-50

Lewis Y (Tumor Marker) (A70-C/C8), 1mg/mL Antibody | BNUM1411-50| Gentaur Distribution US, UK & Europe

Summary.: This antibody recognizes a carbohydrate epitope common to the tumor-associated Lewis Y and Lewis b antigens (Fucalpha1-2Galbeta1-4/3GlcNAcbeta). Its specificity was established without doubt with a panel of 86 synthetic mono- and oligosaccharidic structures. Lewis Y is expressed in large bowel tumors and colorectal carcinomas. It may be useful in the classification of human renal and bladder tumors. The Lewis Y antigen has been evaluated as a clinical marker for the diagnosis and prognosis of cholangiocarcinoma, hepatocellular carcinoma and breast cancer.This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL..

Conjugate: Purified, BSA-free.

Storage Buffer: PBS, no BSA, no azide.

Storage Temperature: 35°C to -5°C .

Application: .

Stability: Stable at room temperature or 37°C (98°F) for 7 days.